Managing the Economics of CHIP and Making the Case for Added Value

Dr. Aaron Grantham of St. Luke’s Mid-American Heart Institute presents how to measure the added value of high-risk PCI by first understanding the underlying economics. Given the cost cutting nature of hospital administrators, health care providers must know the data that determine costs and develop a programmatic approach to measuring value. Tweet this, subscribe or  join … Continue reading “Managing the Economics of CHIP and Making the Case for Added Value”

How to Build a CHIP Protected PCI Program

University of Washington’s Dr. Mark Reisman describes how to develop a CHIP Protected PCI program. In this comprehensive presentation, Dr. Reisman details out the proper steps which include building a multidisciplinary heart team and fostering a CHIP alliance with other hospitals. Tweet this, subscribe or find an Impella training course near you.

How Fellows can Gain Experience Treating CHIP Patients

Dr. Robert Riley of University of Washington Medical Center describes how Fellows can gain experience in treating CHIP patients through a wide variety of resources. Tweet this, subscribe or join the conversation by following us on Twitter: @ProtectedPCI NPS-153-16.v2

The Benefits of a CHIP Fellowship Program

Dr. Raja Hatem discusses the CHIP Fellowship Program designed to train cardiologists to help the underserved, high-risk patients who exhibit low EF, coronary artery calcification, multivessel disease or chronic total occlusion. IMP-231

The Current & Future State of High Risk PCI in a World of Increasing Public Scrutiny

Dr. James McCabe of the University of Washington uses case examples to discuss public reporting and outcomes data and how it affects high-risk PCI programs and procedures. Dr. McCabe presented this at the Expanding Your Practice to Include Complete Revascularization in Higher-Risk Indicated Patients sponsored by the Cardiovascular Research Foundation course held in Seattle this … Continue reading “The Current & Future State of High Risk PCI in a World of Increasing Public Scrutiny”

Benefits of Early Support in High Risk PCI Patients

Dr. Amir Kaki of DMC Heart Hospital shares an Impella case that illustrates the benefits of early hemodynamic support in patients with extensive myocardium risk. Tweet this, subscribe or find educational opportunities near you.

PCI Appears Safe In Surgically Ineligible Patients: ACC.2016 Study

Abiomed poster April 3 - Devraj Sukul, MD #1A large study at a diverse array of hospitals found that PCI appeared to be safe in patients who were said to be ineligible for surgery.Devraj Sukul, MD, of the University of Michigan Health System in Ann Arbor, presented the results in a moderated poster session at ACC.16 on April 3 Chicago. The poster is titled “The Safety of Percutaneous Coronary Intervention in Patients Turned Down for Surgical Revascularization: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.”The trial examined 99,370 patients who underwent PCI between January 2010 and December 2014 at 33 PCI-capable hospitals in Michigan that had on-site cardiac surgery. Patients were excluded if they had STEMI, cardiac arrest, salvage PCI or prior bypass surgery. Continue readingPCI Appears Safe In Surgically Ineligible Patients: ACC.2016 Study